Carlsmed Inc. (CARL)
CARL trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1794546/000119312526071551/0001193125-26-071551-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | CARL on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2025 |
| SEC CIK | 0001794546 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $50.5M |
| Net income | -$29.6M |
| Operating income | -$30.6M |
| Net margin | -58.7% |
| Operating margin | -60.5% |
| Revenue growth | +85.9% |
| Cash | $85.8M |
| Total assets | $130.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 9.4× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-10 |
| Cash and burn | $35.9M cash; operating cash flow -$8.6M a quarter. | Report 2026-09-30 |
| Shares outstanding | 27,404,088 (2026-11-06); 26,592,908 a year earlier. | Cover page 2026-11-06 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 0 424B5 takedowns | Latest 2026-08-14 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Ernst & Young LLP, San Diego, California, United States | PCAOB Form AP 2026-03-13 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $2.6M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $21.6M | -$12.2M | -$8.7M | $35.9M | $15.4M | $71.8M | 10-Q 2026-11-10 |
| Q2 2026 2026-06-30 | $18.9M | -$10.5M | -$7.4M | $46.2M | $15.4M | $63.3M | 10-Q 2026-08-05 |
| Q1 2026 2026-03-31 | $16.1M | -$8.7M | -$13.0M | $73.0M | $15.4M | $56.4M | 10-Q 2026-05-05 |
| Q4 2025 2025-12-31 | $15.2M | -$8.6M | -$5.3M | $85.8M | $15.3M | $50.5M | 10-K 2026-02-25 |
| Q3 2025 2025-09-30 | $13.1M | -$8.5M | -$8.5M | $115.4M | $15.4M | $44.8M | 10-Q 2026-11-10 |
| Q2 2025 2025-06-30 | $12.1M | -$6.8M | -$7.0M | $33.5M | $15.4M | $38.3M | 10-Q 2026-08-05 |
| Q1 2025 2025-03-31 | $10.2M | -$5.7M | -$8.2M | $43.4M | No debt tags | $32.3M | 10-Q 2026-05-05 |
| Q4 2024 2024-12-31 | $9.4M | -$4.7M | -$4.2M | $40.1M | $15.4M | $27.2M | 10-K 2026-02-25 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-08-14 |
| Latest annual report | 10-K | 2026-02-25 |
| Latest quarterly / interim | 10-Q | 2026-11-10 |
| Latest current report | 8-K | 2026-11-10 |
| Latest proxy | DEFA14A | 2026-04-22 |
Source: SEC EDGAR submissions feed, 99 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +17.9% |
| 1 month | +18.3% |
| 3 months | +22.4% |
| Year to date | +38.6% |
| 1 year | +34.6% |
| From 52-week high | -8.0% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| RCEL | Avita Medical Inc. | $15.22 | -2.62% | $478.2M |
| MDXG | MiMedx Group Inc | $3.18 | -0.93% | $464.0M |
| ANGO | AngioDynamics Inc. | $11.78 | -0.76% | $495.4M |
| MOBI | Mobia Medical Inc. | $13.15 | -0.15% | $438.3M |
| SI | Shoulder Innovations Inc. | $20.45 | -1.16% | $427.9M |
| SGHT | Sight Sciences Inc. | $10.59 | -2.22% | $588.6M |
| TCMD | Tactile Systems Technology Inc. | $26.37 | -1.64% | $590.7M |
| SENS | Senseonics Holdings Inc. | $10.90 | +3.02% | $597.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier